Intranasal INI-2004, a novel synthetic TLR4 agonist, is safe, well tolerated, and alleviates nasal congestion in patients with allergic rhinitis: a randomized, double-blind phase I/Ib study
Nasal congestion
DOI:
10.1016/j.jaci.2024.12.521
Publication Date:
2025-02-10T10:03:45Z
AUTHORS (4)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....